BEIJING, July 23, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce its revenue projections for key product lines through the year 2029.
Revenue Projections | |||||
Revenue from hybrid seeds and other | Revenue from NEC | Revenue from GMO | Total Revenue(¥'000) | Total Revenue(US$'000) | |
2022
| ¥52,580 | - | - | ¥52,580 | $7,240 |
2023 | ¥93,307 | - | - | ¥93,307 | $12,848 |
2024 (Expected) | ¥95,000 | ¥10,000 | - | ¥105,000 | $14,458 |
2025 (Expected) | ¥99,750 | ¥50,000 | ¥30,000 | ¥179,750 | $24,751 |
2026 (Expected) | ¥104,738 | ¥100,000 | ¥90,000 | ¥294,738 | $40,585 |
2027 (Expected) | ¥109,974 | ¥150,000 | ¥210,000 | ¥469,974 | $64,715 |
2028 (Expected) | ¥115,473 | ¥225,000 | ¥330,000 | ¥670,473 | $92,324 |
2029 (Expected) | ¥121,247 | ¥337,500 | ¥500,000 | ¥958,747 | $132,019 |
Assumptions:
|
About Origin Agritech Limited
Origin Agritech Limited, founded in 1997 and headquartered in Zhong-Guan-Cun (ZGC) Life Science Park in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's website at www.originagritech.com. The Company also maintains a Twitter account for updating investors on Company and industry developments which is https://x.com/origin_agritech.
For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: [email protected]
Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: [email protected]